Literature DB >> 2775686

Revised FIGO staging for gynaecological cancer.

J H Shepherd1.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2775686     DOI： 10.1111/j.1471-0528.1989.tb03341.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN： 0306-5456


× No keyword cloud information.
  97 in total

1.  Sex-determining region Y-box 2 expression predicts poor prognosis in human ovarian carcinoma.

Authors:  Jing Zhang; Doo Young Chang; Imelda Mercado-Uribe; Jinsong Liu
Journal:  Hum Pathol       Date:  2012-03-07       Impact factor: 3.466

2.  The waiting time paradox: population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland.

Authors:  Simon C Crawford; Jonathan A Davis; Nadeem A Siddiqui; Linda de Caestecker; Charles R Gillis; David Hole; Gillian Penney
Journal:  BMJ       Date:  2002-07-27

3.  Survival advantage of lymphadenectomy in endometrial cancer.

Authors:  Holm Eggemann; Tanja Ignatov; Katharina Kaiser; Elke Burger; Serban Dan Costa; Atanas Ignatov
Journal:  J Cancer Res Clin Oncol       Date:  2016-01-08       Impact factor: 4.553

4.  Outcomes in 24 selected patients with stage IVB cervical cancer and excellent performance status treated with radiotherapy and chemotherapy.

Authors:  Israel Zighelboim; Nicholas P Taylor; Matthew A Powell; Randall K Gibb; Janet S Rader; David G Mutch; Perry W Grigsby
Journal:  Radiat Med       Date:  2006-11-24

5.  A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometrium.

Authors:  Anuja Jhingran; Lois M Ramondetta; Diane C Bodurka; Brian M Slomovitz; Jubilee Brown; Lawrence B Levy; Michael E Garcia; Patricia J Eifel; Karen H Lu; Thomas W Burke
Journal:  Gynecol Oncol       Date:  2013-02-04       Impact factor: 5.482

6.  Long non-coding RNAs, ASAP1-IT1, FAM215A, and LINC00472, in epithelial ovarian cancer.

Authors:  Yuanyuan Fu; Nicoletta Biglia; Zhanwei Wang; Yi Shen; Harvey A Risch; Lingeng Lu; Emilie Marion Canuto; Wei Jia; Dionyssios Katsaros; Herbert Yu
Journal:  Gynecol Oncol       Date:  2016-09-23       Impact factor: 5.482

7.  Transvaginal colour flow imaging: a possible new screening technique for ovarian cancer.

Authors:  T Bourne; S Campbell; C Steer; M I Whitehead; W P Collins
Journal:  BMJ       Date:  1989-12-02

8.  Expression of c-erbB-2, c-myc, and c-ras oncoproteins, insulin-like growth factor receptor I, and epidermal growth factor receptor in ovarian carcinoma.

Authors:  P A van Dam; I B Vergote; D G Lowe; J V Watson; P van Damme; J C van der Auwera; J H Shepherd
Journal:  J Clin Pathol       Date:  1994-10       Impact factor: 3.411

9.  Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.

Authors:  T H Bourne; S Campbell; K M Reynolds; M I Whitehead; J Hampson; P Royston; T J Crayford; W P Collins
Journal:  BMJ       Date:  1993-04-17

10.  The utility of serum human epididymis protein 4 (HE4) in patients with a pelvic mass.

Authors:  Martina Montagnana; Giuseppe Lippi; Orazio Ruzzenente; Valentina Bresciani; Elisa Danese; Silvia Scevarolli; Gian Luca Salvagno; Silvia Giudici; Massimo Franchi; Gian Cesare Guidi
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.